A rating of 91 puts Xeris Pharmaceuticals Inc (XERS) near the top of the Biotechnology industry according to InvestorsObserver. Xeris Pharmaceuticals Inc's score of 91 means it scores higher than 91% of stocks in the industry. Xeris Pharmaceuticals Inc also received an overall rating of 59, putting it above 59% of all stocks. Biotechnology is ranked 104 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 59 means the stock is more attractive than 59 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Xeris Pharmaceuticals Inc Stock Today?
Xeris Pharmaceuticals Inc (XERS) stock is down -3.98% while the S&P 500 is higher by 0.37% as of 11:54 AM on Thursday, May 6. XERS is down -$0.14 from the previous closing price of $3.48 on volume of 1,408,567 shares. Over the past year the S&P 500 has gained 46.85% while XERS is higher by 38.02%. XERS lost -$2.14 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Xeris Pharmaceuticals Inc (XERS) Stock.
